Esophageal Stent Alleviates Benign Strictures
By HospiMedica International staff writers Posted on 06 Mar 2014 |

Image: The WallFlex Nitinol esophageal stent (Photo courtesy of Boston Scientific).
A fully covered metal stent provides new treatment options for patients with benign narrowing of the esophagus.
The WallFlex esophageal stent is made of a nickel-titanium (Nitinol) wire braided construction that provides luminal patency in the presence of strictures or benign tumors. The stent is designed for gradual expansion, typically complete in 24-72 hours; it features a Permalume silicone coating that is designed to prevent tumor in-growth, seal concurrent esophageal fistulas, and help reduce food impaction. The WallFlex Stent also provides physicians with clear visualization during fluoroscopy, aiding in accurate placement, as well as progressive, step flared ends that assist in anchoring the stent within the esophageal lumen.
An additional feature is a Teflon coated polyester suture that enables easy removal for up to eight weeks, potentially saving patients from having to visit the hospital to undergo additional dilations. The WallFlex Esophageal Fully Covered Stent is a product of Boston Scientific (Natick, MA, USA), and has received the European Community CE marking of approval. The stent is not approved for the removal from malignant strictures and has not been approved in the United States for the treatment of refractory benign esophageal strictures.
“Building on the best of Boston Scientific's industry-leading stents, the expanded indication for the WallFlex Esophageal Fully Covered Stent demonstrates our commitment to physician needs and dedication to improving patient outcomes,” said David Pierce, president of endoscopy at Boston Scientific. “This enables physicians in the European Union to provide additional options for the treatment and management of patients suffering from benign esophageal strictures.”
“Fully covered esophageal stents are a valid therapeutic option in patients with benign refractory esophageal strictures,” said Javier Jimenez, MD, chief of the Endoscopy Department at Complejo Hospitalario de Navarra (Pamplona, Spain). “I use the WallFlex Esophageal Stent because its small profile and radiopacity facilitate accurate placement, the migration rate is low, and stent removal is usually easy.”
Benign esophageal strictures are a narrowing or tightening of the esophagus caused by scarring that cause swallowing difficulties. Strictures can be caused by or associated with gastroesophageal reflux disease (GERD), esophagitis, a dysfunctional lower esophageal sphincter, disordered motility, lye ingestion, or a hiatal hernia. Strictures can also form after esophageal surgery and other treatments such as laser therapy or photodynamic therapy (PDT). The primary treatment is dilation of the esophagus, which may need to be repeated after a period if the stricture recurs.
Related Links:
Boston Scientific
The WallFlex esophageal stent is made of a nickel-titanium (Nitinol) wire braided construction that provides luminal patency in the presence of strictures or benign tumors. The stent is designed for gradual expansion, typically complete in 24-72 hours; it features a Permalume silicone coating that is designed to prevent tumor in-growth, seal concurrent esophageal fistulas, and help reduce food impaction. The WallFlex Stent also provides physicians with clear visualization during fluoroscopy, aiding in accurate placement, as well as progressive, step flared ends that assist in anchoring the stent within the esophageal lumen.
An additional feature is a Teflon coated polyester suture that enables easy removal for up to eight weeks, potentially saving patients from having to visit the hospital to undergo additional dilations. The WallFlex Esophageal Fully Covered Stent is a product of Boston Scientific (Natick, MA, USA), and has received the European Community CE marking of approval. The stent is not approved for the removal from malignant strictures and has not been approved in the United States for the treatment of refractory benign esophageal strictures.
“Building on the best of Boston Scientific's industry-leading stents, the expanded indication for the WallFlex Esophageal Fully Covered Stent demonstrates our commitment to physician needs and dedication to improving patient outcomes,” said David Pierce, president of endoscopy at Boston Scientific. “This enables physicians in the European Union to provide additional options for the treatment and management of patients suffering from benign esophageal strictures.”
“Fully covered esophageal stents are a valid therapeutic option in patients with benign refractory esophageal strictures,” said Javier Jimenez, MD, chief of the Endoscopy Department at Complejo Hospitalario de Navarra (Pamplona, Spain). “I use the WallFlex Esophageal Stent because its small profile and radiopacity facilitate accurate placement, the migration rate is low, and stent removal is usually easy.”
Benign esophageal strictures are a narrowing or tightening of the esophagus caused by scarring that cause swallowing difficulties. Strictures can be caused by or associated with gastroesophageal reflux disease (GERD), esophagitis, a dysfunctional lower esophageal sphincter, disordered motility, lye ingestion, or a hiatal hernia. Strictures can also form after esophageal surgery and other treatments such as laser therapy or photodynamic therapy (PDT). The primary treatment is dilation of the esophagus, which may need to be repeated after a period if the stricture recurs.
Related Links:
Boston Scientific
Latest Surgical Techniques News
- Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next
- World’s First Custom Anterior Cervical Spine Surgery Performed Using Personalized Implant
- Implantable Biodegradable Scaffold Helps Broken Bones Regrow Quickly
- First Human Spinal Cord Repair Using Patient Own Cells Could Cure Paralysis
- 'Dual-Mode' Tracer Enables Surgeons to See and Hear Prostate Cancer
- Pioneering One-Stage Hybrid Surgery Ensures Safer Outcomes in Brain and Spine Tumors
- Reimplanting Lab-Grown Patient Cartilage Accelerates Healing After Hip Surgery
- Diamond-Based Sensor Pinpoints Metastasized Cancer for Surgical Removal
- Minimally Invasive Valve Repair Improves Survival in Elderly AFMR Patients
- Tiny Soft Robots Dissolve Painful Kidney Stones with Targeted Drug Delivery
- Implantable 3D Patch Closes and Repairs Heart Defects
- New Endoscopy Technology Enables Early Detection of Esophageal Cancer
- New Implant Enables Women to Access Hip Resurfacing Surgery
- Surgical Micro-Robot Sees and Corrects Movements from Within
- AI Cuts Diagnostic Delays in Prostate Cancer
- 'Google Maps' for Surgeons to Help Perform Complex Robot-Assisted Esophagectomy
Channels
Critical Care
view channel
AI Model Identifies AF Patients Requiring Blood Thinners to Prevent Stroke
Atrial fibrillation (AF) is the most common abnormal heart rhythm, affecting around 59 million people globally. It increases stroke risk because quivering in the upper heart chambers allows blood clots... Read more
Soft Robot Intubation Device Could Save Lives
Maintaining an open airway is one of the most critical priorities in emergency medicine, as without oxygen flow, other interventions can quickly fail. Endotracheal intubation is the gold standard but remains... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more